Clinical Trial Update: A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy, safety, and pharmacokinetics of the Port Delivery System delivering ranibizumab in Chinese participants with neo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neovascular Age-related Macular Degeneration, nAMD | Phase 3 | Status: RECRUITING